Premium
Urinary serotonin metabolite excretion during cisplatin chemotherapy
Author(s) -
WilderSmith Oliver H. G.,
Borgeat Alain,
Chappuis Pierre,
Fathi Marc,
Forni Michel
Publication year - 1993
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19931001)72:7<2239::aid-cncr2820720729>3.0.co;2-5
Subject(s) - ondansetron , vomiting , antiemetic , nausea , medicine , serotonin , anesthesia , chemotherapy , dexamethasone , urinary system , pharmacology , receptor
Background . Nausea and vomiting associated with cisplatin chemotherapy is a source of major morbidity that remains difficult to control. Acute phase (0‐24 hours after induction of chemotherapy) nausea and vomiting parallels plasma serotonin release, which explains the effectiveness of 5HT3 antagonists; serotonin release in the delayed phase (24–48 hours after induction), during which consistent antiemetic control remains elusive, has not been investigated. The effect of propofol, a recent addition to the antiemetic armamentarium, on this serotonin release has not been studied. Methods . Ten women with nausea and vomiting refractory to ondansetron and dexamethasone prophylaxis in their first cisplatin chemotherapy cycle were studied. Serial urinary 5‐hydroxyindoleacetic acid (5‐HIAA) levels were determined during a 48‐hour period in 30 subsequent cycles, conducted under ondansetron/dexamethasone prophylaxis together with a propofol infusion. Results . There was a significant urinary 5‐HIAA peak 6 hours after induction of chemotherapy, with no peaks thereafter. Propofol did not inhibit serotonin release. Conclusions . Cisplatin chemotherapy is associated with serotonin release in the acute phase. There is no serotonin release during the delayed phase. Thus the use of 5HT3 antagonists for delayed‐phase nausea and vomiting would appear questionable.